In Vitro Diagnostics Market to 2018 - Consolidation, Decentralization and Demand for Genetic Testing to Shape the Competitive Landscape
NEW YORK, March 28, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
http://www.reportlinker.com/p0804711/In-Vitro-Diagnostics-Market-to-2018---Consolidation-Decentralization-and-Demand-for-Genetic-Testing-to-Shape-the-Competitive-Landscape.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic
In Vitro Diagnostics Market to 2018 - Consolidation, Decentralization and Demand for Genetic Testing to Shape the Competitive Landscape
Summary
GBI Research's report, "In Vitro Diagnostics Market to 2018 - Consolidation, Decentralization and Demand for Genetic Testing to Shape the Competitive Landscape" provides key data, information and analysis on the global In Vitro Diagnostics (IVD) market. The report provides market landscape, competitive landscape and market trends information on seven IVD market categories: immunochemistry, clinical chemistry, infectious immunology, hematology, microbiology culture, histology and cytology and genetic testing. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, with analysis of the major Mergers and Acquisitions (M&A) in the last four years and a detailed analysis of the pipeline products in each category. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.
Scope
- The key geographies include, the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
- Market size data for seven In Vitro Diagnostics market categories – immunochemistry, clinical chemistry, infectious immunology, hematology, microbiology culture, histology and cytology and genetic testing.
- Annualized market revenue data, seven-year forecasts through to 2018, as well as company share data for 2010.
- Qualitative analysis of key market trends for the In Vitro Diagnostics market.
- Qualitative analysis of market drivers and restraints in each category within the In Vitro Diagnostics market.
- The report also covers information on the leading market players, the competitive landscape, and the leading technologies in the market
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the In Vitro Diagnostics market globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Identify the players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products most likely to ensure a robust return.
- What's the next big thing in the the In Vitro Diagnostics market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global In Vitro Diagnostics market and the factors shaping it.
1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 9
1.2 List of Figures 10
2 Introduction 12
2.1 GBI Research Guidance 12
3 Global In Vitro Diagnostics Market: Market Characterization 13
3.1 Global in Vitro Diagnostics Market, Revenue ($bn), 2004–2011 13
3.2 Global In Vitro Diagnostics Market, Revenue ($bn), 2011–2018 15
3.3 Global In Vitro Diagnostics Market, Key Company Shares (%), 2010 17
3.4 Global In Vitro Diagnostics Market: Key Market Trends 18
3.4.1 Growing Trend towards Preventive Healthcare is Driving the Growth of In Vitro Diagnostics 18
3.4.2 Increased Use of Information Technology in IVD for Effective Workflow Management 19
3.4.3 Laboratory Consolidation is a Major Trend in the IVD Industry 20
3.4.4 Demand for Decentralized Laboratory Testing is increasing Significantly Across the World 22
3.4.5 Consolidation Activity has Increased Significantly in the IVD Industry in Recent Years 22
3.4.6 Automation is the Key Technology Trend in IVD Market 23
3.5 Global In Vitro Diagnostics Market: Market Dynamics 25
3.5.1 Market Drivers 25
3.5.2 Market Restraints 26
4 Global In Vitro Diagnostics Market: Market Category Analysis and Forecasts 27
4.1 In Vitro Diagnostics Market: Cross-Category Analysis 27
4.2 Immunochemistry 29
4.2.1 Immunochemistry Market, Global, Revenue ($m), 2004–2011 29
4.2.2 Immunochemistry Market, Global, Revenue ($m), 2011–2018 30
4.2.3 Immunochemistry Market, Global, Company Share, (%), 2010 31
4.3 Immunochemistry Market: Market Dynamics 32
4.3.1 Market Drivers 32
4.3.2 Market Restraints 34
4.4 Clinical Chemistry 35
4.4.1 Clinical Chemistry Market, Global, Revenue ($m), 2004–2011 35
4.4.2 Clinical Chemistry Market, Global, Revenue ($m), 2011–2018 36
4.4.3 Clinical Chemistry Market, Global, Key Company Shares, (%), 2010 37
4.5 Clinical Chemistry Market: Market Dynamics 38
4.5.1 Market Drivers 38
4.5.2 Market Restraints 40
4.6 Infectious Immunology 41
4.6.1 Infectious Immunology Market, Global, Revenue ($m), 2004–2011 41
4.6.2 Infectious Immunology Market, Global, Revenue ($m), 2011–2018 42
4.6.3 Infectious Immunology Market, Global, Key Company Shares, (%), 2010 43
4.7 Infectious Immunology Market: Market Dynamics 44
4.7.1 Market Drivers 44
4.7.2 Market Restraints 45
4.8 Hematology 46
4.8.1 Hematology Market, Global, Revenue ($m), 2004–2011 46
4.8.2 Hematology Market, Global, Revenue ($m), 2011–2018 47
4.8.3 Hematology Market, Global, Key Company Shares, (%), 2010 48
4.9 Hematology Market: Market Dynamics 49
4.9.1 Market Drivers 49
4.9.2 Market Restraints 49
4.10 Microbiology Culture 50
4.10.1 Microbiology Culture Market, Global, Revenue ($m), 2004–2011 50
4.10.2 Microbiology Culture Market, Global, Revenue ($m), 2011–2018 51
4.10.3 Microbiology Culture Market, Global, Company Shares, (%), 2010 52
4.11 Microbiology Culture Market: Market Dynamics 53
4.11.1 Market Drivers 53
4.11.2 Market Restraints 53
4.12 Histology and Cytology 54
4.12.1 Histology and Cytology Market, Global, Revenue ($m), 2004–2011 54
4.12.2 Histology and Cytology Market, Global, Revenue ($m), 2011–2018 55
4.12.3 Histology and Cytology Market, Global, Company Share, (%), 2010 56
4.13 Histology and Cytology Market: Market Dynamics 57
4.13.1 Market Drivers 57
4.13.2 Market Restraints 57
4.14 Genetic Testing 58
4.14.1 Genetic Testing Market, Global, Revenue ($m), 2004–2011 58
4.14.2 Genetic Testing Market, Global, Revenue ($m), 2011–2018 59
4.14.3 Genetic Testing Market, Global, Company Share, (%), 2010 60
4.15 Genetic Testing Market: Market Dynamics 61
4.15.1 Market Drivers 61
4.15.2 Market Restraints 62
5 Global In Vitro Diagnostics Market: Country Analysis and Forecasts 63
5.1 In Vitro Diagnostics Market: Cross-Country Analysis 63
5.2 Historic and Forecast Revenue, By Country 65
5.2.1 In Vitro Diagnostics Market, The US, Revenue ($m), 2004–2011 65
5.2.2 In Vitro Diagnostics Market, the US, Revenue ($m), 2011–2018 66
5.2.3 In Vitro Diagnostics Market, Canada, Revenue ($m), 2004–2011. 67
5.2.4 In Vitro Diagnostics Market, Canada, Revenue ($m), 2011–2018 68
5.2.5 In Vitro Diagnostics Market, the UK, Revenue ($m), 2004–2011 69
5.2.6 In Vitro Diagnostics Market, the UK, Revenue ($m), 2011–2018 70
5.2.7 In Vitro Diagnostics Market, Germany, Revenue ($m), 2004–2011 71
5.2.8 In Vitro Diagnostics Market, Germany, Revenue ($m), 2011–2018 72
5.2.9 In Vitro Diagnostics Market, France, Revenue ($m), 2004–2011 73
5.2.10 In Vitro Diagnostics Market, France, Revenue ($m), 2011–2018 74
5.2.11 In Vitro Diagnostics Market, Italy, Revenue ($m), 2004–2011 75
5.2.12 In Vitro Diagnostics Market, Italy, Revenue ($m), 2011–2018 76
5.2.13 In Vitro Diagnostics Market, Spain, Revenue ($m), 2004–2011 77
5.2.14 In Vitro Diagnostics Market, Spain, Revenue ($m), 2011–2018 78
5.2.15 In Vitro Diagnostics Market, Japan, Revenue ($m), 2004–2011 79
5.2.16 In Vitro Diagnostics Market, Japan, Revenue ($m), 2011–2018 80
5.2.17 In Vitro Diagnostics Market, China, Revenue ($m), 2004–2011 81
5.2.18 In Vitro Diagnostics Market, China, Revenue ($m), 2011–2018 82
5.2.19 In Vitro Diagnostics Market, India, Revenue ($m), 2004–2011 83
5.2.20 In Vitro Diagnostics Market, India, Revenue ($m), 2011–2018 84
5.2.21 In Vitro Diagnostics Market, Australia, Revenue ($m), 2004–2011 85
5.2.22 In Vitro Diagnostics Market, Australia, Revenue ($m), 2011–2018 86
5.2.23 In Vitro Diagnostics Market, Brazil, Revenue ($m), 2004–2011 87
5.2.24 In Vitro Diagnostics Market, Brazil, Revenue ($m), 2011–2018 88
6 Global In Vitro Diagnostics Market: Competitive Assessment 89
6.1 Key Market Participants 90
6.1.1 F. Hoffmann–La Roche Ltd. 90
6.1.2 Siemens Healthcare (Subsidiary of Siemens AG) 91
6.1.3 Abbott Laboratories 92
6.1.4 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation) 93
6.1.5 Ortho–Clinical Diagnostics Inc. (Subsidiary of Johnson & Johnson) 94
6.1.6 bioMerieux S.A. (Subsidiary of Merieux Alliance group) 94
6.1.7 Sysmex Corporation (Sysmex) 95
6.1.8 Becton, Dickinson and Company 96
6.1.9 Bio–Rad Laboratories, Inc. (Bio–Rad) 97
6.1.10 Alere Inc. (formerly Inverness Medical Innovations, Inc.) 98
7 Global In Vitro Diagnostics Market: Product Pipeline Analysis 99
7.1 In Vitro Diagnostics Market: Pipeline Products Summary 99
7.1.1 Pipeline Products Analysis: Immunochemistry Market 101
7.1.2 Pipeline Products Analysis: Infectious Immunology 102
7.1.3 Pipeline Products Analysis: Genetic Testing 103
7.1.4 Pipeline Products Analysis: Clinical Chemistry 104
7.1.5 Pipeline Products Analysis: Hematology 105
7.1.6 Pipeline Products Analysis: Microbiology Culture 106
7.1.7 Pipeline Products Analysis: Histology and Cytology 107
7.2 In Vitro Diagnostics Market: Profiles of Key Pipeline Products 108
7.2.1 ImmProCon Technology 108
7.2.2 RAPIDPoint 500 System – Lactate Assay 108
7.2.3 Sali – Chek Reader 108
7.2.4 Point-of-Care Diagnostic Device 109
7.2.5 ACE Alera Clinical Chemistry System – Direct A1c Assay 109
7.2.6 Advia 120 Hematology System – IRF Test 109
7.2.7 Advia 2120 Hematology System – MPC Test 110
7.2.8 AIA–600 II – D–dimer Test 110
8 Global In Vitro Diagnostics Market: Consolidation Landscape 111
8.1 Deals by Number, 2008–2011 111
8.2 In Vitro Diagnostics Market: Key Deals, 2008–2011 119
8.2.1 Roche Completes Acquisition of mtm laboratories 119
8.2.2 bioMerieux Acquires Argene 119
8.2.3 Thermo Fisher Completes Acquisition of Phadia 119
8.2.4 Quest Diagnostics Completes Acquisition of Athena Diagnostics 120
8.2.5 Danaher Completes Acquisition of Beckman Coulter 120
8.2.6 Laboratory Corporation of America Completes Acquisition of Genzyme Genetics From Genzyme 121
8.2.7 Merck Completes Acquisition of Millipore 121
8.2.8 Thermo Fisher Scientific Completes Acquisition of Ahura Scientific 121
8.2.9 Inverness Medical Innovations Acquires 78.13% Stake in Standard Diagnostics 122
8.2.10 Quidel Completes Acquisition of Diagnostic HYBRIDS 122
8.2.11 Danaher Completes Acquisition of Genetix Group 122
8.2.12 QIAGEN Completes Acquisition of DxS 122
8.2.13 Thermo Fisher Scientific Completes Acquisition of B.R.A.H.M.S. 123
8.2.14 Laboratory Corporation of America Holdings Completes Acquisition of Monogram Biosciences 123
8.2.15 Inverness Medical Innovations Completes Acquisition of Concateno From Marwyn 124
8.2.16 Gen–Probe Acquires Tepnel Life Sciences 124
8.2.17 Hologic Acquires Third Wave Technologies 124
8.2.18 Immucor Acquires BioArray Solutions 124
8.2.19 Werfen Life Acquires INOVA Diagnostics 125
8.2.20 Abbott Laboratories Acquires Ibis Biosciences from Isis Pharmaceuticals 125
8.2.21 bioMerieux Acquires AviaraDx 125
8.2.22 Bio–Rad Laboratories Acquires Diamed 126
9 Appendix 127
9.1 Definitions 127
9.1.1 Clinical Chemistry 127
9.1.2 Immunochemistry Test Reagents 128
9.1.3 Hematology 129
9.1.4 Histology And Cytology 130
9.1.5 Microbiology Culture 131
9.1.6 Infectious Immunology 131
9.1.7 Genetic Testing 132
9.2 Sources 132
9.3 Acronyms 132
9.4 Research Methodology 133
9.4.1 Secondary Research 133
9.4.2 Primary Research 134
9.4.3 Models 134
9.4.4 Forecasts 134
9.4.5 Expert Panels 134
9.5 Contact Us 135
9.6 Disclaimer 135
1.1 List of Tables
Table 1: In Vitro Diagnostics Market, Global, Revenue ($bn), 2004–2011 13
Table 2: In Vitro Diagnostics Market, Global, Revenue ($bn), 2011–2018 15
Table 3: Global In Vitro Diagnostics Market, Key Company, Revenue ($m) 2010 17
Table 4: In Vitro Diagnostics Market, Global, Diagnostics Laboratories, Key M&A Deals, 2007 20
Table 5: In Vitro Diagnostics Market, Global, Diagnostics Laboratories, Key M&A Deals, 2008–2009 21
Table 6: Key M&A, IVD Market, Global, 2010–2011 23
Table 7: In Vitro Diagnostics Market, Global, Cross Category Analysis ,CAGR (%), 2004–2018 27
Table 8: Immunochemistry Market, Global, Revenue ($m), 2004–2011 29
Table 9: Immunochemistry Market, Global, Revenue ($m), 2011–2018 30
Table 10: Global Immunochemistry Market, Key Company, Revenue ($m) 2010 31
Table 11: Global Immunochemistry Market, Tumor Markers 33
Table 12: Clinical Chemistry Market, Global, Revenue ($m), 2004–2011 35
Table 13: Clinical Chemistry Market, Global, Revenue ($m), 2011–2018 36
Table 14: Clinical Chemistry Market, Global, Key Company Revenue ($m), 2010 37
Table 15: Infectious Immunology Market, Global, Revenue ($m), 2004–2011 41
Table 16: Infectious Immunology Market, Global, Revenue ($m), 2011–2018 42
Table 17: Infectious Immunology Market, Global, Key Company, Revenue ($m) 2010 43
Table 18: Hematology Market, Global, Revenue ($m), 2004–2011 46
Table 19: Hematology Market, Global, Revenue ($m), 2011–2018 47
Table 20: Hematology Market, Global, Key Company Revenue ($m), 2010 48
Table 21: Microbiology Culture Market, Global, Revenue ($m), 2004–2011 50
Table 22: Microbiology Culture Market, Global, Revenue ($m), 2011–2018 52
Table 23: Microbiology Culture Market, Global, Key Company Revenue ($m), 2010 53
Table 24: Histology and Cytology Market, Global, Revenue ($m), 2004–2011 54
Table 25: Histology and Cytology Market, Global, Revenue ($m), 2011–2018 55
Table 26: Histology and Cytology Market, Global, Key Company, Revenue ($m) 2010 56
Table 27: Genetic Testing Market, Global, Revenue ($m), 2004–2011 58
Table 28: Genetic Testing Market, Global, Revenue ($m), 2011–2018 59
Table 29: Genetic Testing Market, Global, Key Company Revenue ($m), 2010 60
Table 30: In Vitro Diagnostics Market, Global, Genetic Testing, Home Genetic Test Kits, Examples 61
Table 31: IVD Market, Global, Cross-Country Analysis, CAGR (%), 2004–2018 63
Table 32: In Vitro Diagnostics Market, The US, Revenue ($m), 2004–2011 65
Table 33: In Vitro Diagnostics Market, The US, Revenue ($m), 2011–2018 66
Table 34: In Vitro Diagnostics Market, Canada, Revenue ($m), 2004–2011 67
Table 35: In Vitro Diagnostics Market, Canada, Revenue ($m), 2011–2018 68
Table 36: In Vitro Diagnostics Market, The UK, Revenue ($m), 2004–2011 69
Table 37: In Vitro Diagnostics Market, The UK, Revenue ($m), 2011–2018 70
Table 38: In Vitro Diagnostics Market, Germany, Revenue ($m), 2004–2011 71
Table 39: In Vitro Diagnostics Market, the Germany, Revenue ($m), 2011–2018 72
Table 40: In Vitro Diagnostics Market, France, Revenue ($m), 2004–2011 73
Table 41: In Vitro Diagnostics Market, France, Revenue ($m), 2011–2018 74
Table 42: In Vitro Diagnostics Market, Italy, Revenue ($m), 2004–2011 75
Table 43: In Vitro Diagnostics Market, Italy, Revenue ($m), 2011–2018 76
Table 44: In Vitro Diagnostics Market, Spain, Revenue ($m), 2004–2011 77
Table 45: In Vitro Diagnostics Market, Spain, Revenue ($m), 2011–2018 78
Table 46: In Vitro Diagnostics Market, Japan, Revenue ($m), 2004–2011 79
Table 47: In Vitro Diagnostics Market, Japan, Revenue ($m), 2011–2018 80
Table 48: In Vitro Diagnostics Market, China, Revenue ($m), 2004–2011 81
Table 49: In Vitro Diagnostics Market, China, Revenue ($m), 2011–2018 82
Table 50: In Vitro Diagnostics Market, India, Revenue ($m), 2004–2011 83
Table 51: In Vitro Diagnostics Market, India, Revenue ($m), 2011–2018 84
Table 52: In Vitro Diagnostics Market, Australia, Revenue ($m), 2004–2011 85
Table 53: In Vitro Diagnostics Market, Australia, Revenue ($m), 2011–2018 86
Table 54: In Vitro Diagnostics Market, Brazil, Revenue ($m), 2004–2011 87
Table 55: In Vitro Diagnostics Market, Brazil, Revenue ($m), 2011–2018 88
Table 56: In Vitro Diagnostics (IVD) Market, Global, Pipeline Products by Category, 2011 99
Table 57: In Vitro Diagnostics Market, Pipeline Assessment, by Development Stage 100
Table 58: Immunochemistry Market, Global, Pipeline Products Analysis, 2011 101
Table 59: Infectious Immunology Market, Global, Pipeline Products Analysis, 2011 102
Table 60: Genetic Testing Market, Global, Pipeline Products Analysis, 2011 103
Table 61: Clinical Chemistry Market, Global, Pipeline Products Analysis, 2011 104
Table 62: Hematology Market, Global, Pipeline Products Analysis, 2011 105
Table 63: Microbiology Culture Market, Global, Pipeline Products Analysis, 2011 106
Table 64: Histology and Cytology Market, Global, Pipeline Products Analysis, 2011 107
Table 65: ImmProCon Technology, Product Status, 2011 108
Table 66: RAPIDPoint 500 System, Product Status, 2011 108
Table 67: Sali – Chek Reader, Product Status, 2011 108
Table 68: Point-of-Care Diagnostic Device, Product Status, 2011 109
Table 69: ACE Alera Clinical Chemistry System – Direct A1c Assay, Product Status, 2011 109
Table 70: Advia 120 Hematology System – IRF (Immature Reticulocyte Fraction) Test, Product Status, 2011 109
Table 71: Advia 2120 Hematology System – MPC (Mean Platelet Component) Test, Product Status, 2011 110
Table 72: AIA (Automated Immunoassay Analyzer)–600 II – D–dimer Test, Product Status, 2011 110
Table 73: IVD Market, Mergers and Acquisitions, Number of Deals, Global, 2008–2011 111
Table 74: In Vitro Diagnostics Market, Global, Mergers and Acquisitions, 2008 112
Table 75: In Vitro Diagnostics Market, Global, Mergers and Acquisitions, 2009 – Table 1 113
Table 76: In Vitro Diagnostics Market, Global, Mergers and Acquisitions, 2009 – Table 2 114
Table 77: In Vitro Diagnostics Market, Global, Mergers and Acquisitions, 2010 – Table 1 115
Table 78: In Vitro Diagnostics Market, Global, Mergers and Acquisitions, 2010 – Table 2 116
Table 79: In Vitro Diagnostics Market, Global, Mergers and Acquisitions, 2011 – Table 1 117
Table 80: In Vitro Diagnostics Market, Global, Mergers and Acquisitions, 2011 – Table 2 118
1.2 List of Figures
Figure 1: In Vitro Diagnostics Market, Global, Revenue ($bn), 2004–2011 13
Figure 2: In Vitro Diagnostics Market, Global, Revenue ($bn), 2011–2018 15
Figure 3: Global In Vitro Diagnostics Market, Key Company Shares (%), 2010 17
Figure 4: In Vitro Diagnostics Market, Global, Cross-Category Analysis , CAGR (%), 2004–2018 27
Figure 5: Immunochemistry Market, Global, Revenue ($m), 2004–2011 29
Figure 6: Immunochemistry Market, Global, Revenue ($m), 2011–2018 30
Figure 7: Immunochemistry Market, Global, Company Share, (%), 2010 31
Figure 8: Clinical Chemistry Rapid Tests & POC Market, Global, Revenue ($m), 2004–2011 35
Figure 9: Clinical Chemistry Market, Global, Revenue ($m), 2011–2018 36
Figure 10: Clinical Chemistry Market, Global, Key Company, Revenues ($m) 2010 37
Figure 11: Infectious Immunology Market, Global, Revenue ($m), 2004–2011 41
Figure 12: Infectious Immunology Market, Global, Revenue ($m), 2011–2018 42
Figure 13: Infectious Immunology Market, Global, Key Company Shares, (%), 2010 43
Figure 14: Hematology Market, Global, Revenue ($m), 2004–2011 46
Figure 15: Hematology Market, Global, Revenue ($m), 2011–2018 47
Figure 16: Hematology Market, Global, Key Company Shares, (%), 2010 48
Figure 17: Microbiology Culture Market, Global, Revenue ($m), 2004–2011 50
Figure 18: Microbiology Culture Market, Global, Revenue ($m), 2011–2018 51
Figure 19: Microbiology Culture Market, Global, Company Shares, (%), 2010 52
Figure 20: Histology and Cytology Market, Global, Revenue ($m), 2004–2011 54
Figure 21: Histology and Cytology Market, Global, Revenue ($m), 2011–2018 55
Figure 22: Histology and Cytology Market, Global, Company Share, (%), 2010 56
Figure 23: Genetic Testing Market, Global, Revenue ($m), 2004–2011 58
Figure 24: Genetic Testing Market, Global, Revenue ($m), 2011–2018 59
Figure 25: Genetic Testing Market, Global, Company Share, (%), 2010 60
Figure 26: In Vitro Diagnostics Market, Global, Cross-Country Analysis, CAGR (%), 2004–2018 63
Figure 27: In Vitro Diagnostics Market, The US, Revenue ($m), 2004–2011 65
Figure 28: In Vitro Diagnostics Market, the US, Revenue ($m), 2011–2018 66
Figure 29: In Vitro Diagnostics Market, Canada, Revenue ($m), 2004–2011 67
Figure 30: In Vitro Diagnostics Market, Canada, Revenue ($m), 2011–2018 68
Figure 31: In Vitro Diagnostics Market, The UK, Revenue ($m), 2004–2011 69
Figure 32: In Vitro Diagnostics Market, The UK, Revenue ($m), 2011–2018 70
Figure 33: In Vitro Diagnostics Market, Germany, Revenue ($m), 2004–2011 71
Figure 34: In Vitro Diagnostics Market, the Germany, Revenue ($m), 2011–2018 72
Figure 35: In Vitro Diagnostics Market, France, Revenue ($m), 2004–2011 73
Figure 36: In Vitro Diagnostics Market, France, Revenue ($m), 2011–2018 74
Figure 37: In Vitro Diagnostics Market, Italy, Revenue ($m), 2004–2011 75
Figure 38: In Vitro Diagnostics Market, Italy, Revenue ($m), 2011–2018 76
Figure 39: In Vitro Diagnostics Market, Spain, Revenue ($m), 2004–2011 77
Figure 40: In Vitro Diagnostics Market, Spain, Revenue ($m), 2011–2018 78
Figure 41: In Vitro Diagnostics Market, Japan, Revenue ($m), 2004–2011 79
Figure 42: In Vitro Diagnostics Market, Japan, Revenue ($m), 2011–2018 80
Figure 43: In Vitro Diagnostics Market, China, Revenue ($m), 2004–2011 81
Figure 44: In Vitro Diagnostics Market, China, Revenue ($m), 2011–2018 82
Figure 45: In Vitro Diagnostics Market, India, Revenue ($m), 2004–2011 83
Figure 46: In Vitro Diagnostics Market, India, Revenue ($m), 2011–2018 84
Figure 47: In Vitro Diagnostics Market, Australia, Revenue ($m), 2004–2011 85
Figure 48: In Vitro Diagnostics Market, Australia, Revenue ($m), 2011–2018 86
Figure 49: In Vitro Diagnostics Market, Brazil, Revenue ($m), 2004–2011 87
Figure 50: In Vitro Diagnostics Market, Brazil, Revenue ($m), 2011–2018 88
Figure 51: In Vitro Diagnostics Market, Global, Competitive Assessment 89
Figure 52: In Vitro Diagnostics Market, Global, Pipeline Product Summary (%), 2010 99
Figure 53: In Vitro Diagnostics Market, Pipeline Assessment, by Development Stage 100
Figure 54: Immunochemistry Market, Global, Pipeline Products Analysis, 2011 101
Figure 55: Infectious Immunology Market, Global, Pipeline Products Analysis, 2011 102
Figure 56: Genetic Testing Market, Global, Pipeline Products Analysis, 2011 103
Figure 57: Clinical Chemistry Market, Global, Pipeline Products Analysis, 2011 104
Figure 58: Hematology Market, Global, Pipeline Products Analysis, 2011 105
Figure 59: Microbiology Culture Market, Global, Pipeline Products Analysis, 2011 106
Figure 60: Histology and Cytology Market, Global, Pipeline Products Analysis, 2011 107
Figure 61: Cardiovascular Devices Market, Mergers and Acquisitions, Number of Deals, Global, 2008–2011 111
Companies mentioned
F. Hoffmann–La Roche Ltd.
Siemens Healthcare (Subsidiary of Siemens AG)
Abbott Laboratories
Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
Ortho–Clinical Diagnostics Inc. (Subsidiary of Johnson & Johnson)
bioMerieux S.A. (Subsidiary of Merie
To order this report:
In Vitro Diagnostic Industry: In Vitro Diagnostics Market to 2018 - Consolidation, Decentralization and Demand for Genetic Testing to Shape the Competitive Landscape
Check our Industry Analysis and Insights
CONTACT:
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article